Literature DB >> 7880233

The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina.

G Liuzzo1, L M Biasucci, J R Gallimore, R L Grillo, A G Rebuzzi, M B Pepys, A Maseri.   

Abstract

BACKGROUND: The pathogenesis of unstable angina is poorly understood, and predicting the prognosis at the time of hospital admission is problematic. Recent evidence suggests that there may be active inflammation, possibly in the coronary arteries, in this syndrome. We therefore studied the prognostic value of measurements of the circulating acute-phase reactants C-reactive protein and serum amyloid A protein, which are sensitive indicators of inflammation.
METHODS: We measured C-reactive protein, serum amyloid A protein, creatine kinase, and cardiac troponin T in 32 patients with chronic stable angina, 31 patients with severe unstable angina, and 29 patients with acute myocardial infarction.
RESULTS: At the time of hospital admission, creatine kinase and cardiac troponin T levels were normal in all the patients, but the levels of C-reactive protein and serum amyloid A protein were > or = 0.3 mg per deciliter (exceeding the 90th percentile of the normal distribution) in 4 of the patients with stable angina (13 percent), 20 of the patients with unstable angina (65 percent), and 22 of the patients with acute myocardial infarction (76 percent). The 20 patients with unstable angina who had levels of C-reactive protein and serum amyloid A protein > or = 0.3 mg per deciliter had more ischemic episodes in the hospital than those with levels < 0.3 mg per deciliter (mean [+/- SD] number of episodes per patient, 4.8 +/- 2.5 vs. 1.8 +/- 2.4; P = 0.004); 5 patients subsequently had a myocardial infarction, 2 died, and 12 required immediate coronary revascularization. In contrast, no deaths or myocardial infarction occurred among the 11 patients with levels of C-reactive protein and serum amyloid A protein < 0.3 mg per deciliter, and only 2 of them required coronary revascularization. Among the patients admitted with a diagnosis of acute myocardial infarction, unstable angina preceded infarction in 14 of the 22 patients (64 percent) with levels of C-reactive protein and serum amyloid A protein > or = 0.3 mg per deciliter but in none of the 7 patients with levels < 0.3 mg per deciliter.
CONCLUSIONS: Elevation of the sensitive acute-phase proteins C-reactive protein and serum amyloid A protein at the time of hospital admission predicts a poor outcome in patients with unstable angina and may reflect an important inflammatory component in the pathogenesis of this condition.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7880233     DOI: 10.1056/NEJM199408183310701

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  293 in total

Review 1.  Guideline for the management of patients with acute coronary syndromes without persistent ECG ST segment elevation. British Cardiac Society Guidelines and Medical Practice Committee and Royal College of Physicians Clinical Effectiveness and Evaluation Unit.

Authors: 
Journal:  Heart       Date:  2001-02       Impact factor: 5.994

Review 2.  Chlamydia pneumoniae and atherosclerosis.

Authors:  J D Rutherford
Journal:  Curr Atheroscler Rep       Date:  2000-05       Impact factor: 5.113

Review 3.  Management of unstable angina based on considerations of aetiology.

Authors:  E Braunwald
Journal:  Heart       Date:  1999-09       Impact factor: 5.994

Review 4.  Pathogenic mechanisms in unstable angina.

Authors:  A Maseri; G Liuzzo; L M Biasucci
Journal:  Heart       Date:  1999-09       Impact factor: 5.994

5.  The renaissance of C reactive protein.

Authors:  M B Pepys; A Berger
Journal:  BMJ       Date:  2001-01-06

6.  Interleukin 18 in acute myocardial infarction.

Authors:  Y Seta; T Kanda; T Tanaka; M Arai; K Sekiguchi; T Yokoyama; M Kurimoto; J Tamura; M Kurabayashi
Journal:  Heart       Date:  2000-12       Impact factor: 5.994

7.  Exercise induced myocardial ischaemia does not cause increase in C-reactive protein concentration.

Authors:  A Gaspardone; M Perino; A S Ghini; F Tomai; F Versaci; I Proietti; F Crea
Journal:  Heart       Date:  2000-12       Impact factor: 5.994

Review 8.  Regular review: treatment possibilities for unstable angina.

Authors:  A Manhapra; S Borzak
Journal:  BMJ       Date:  2000-11-18

9.  Cumulative risk assessment in unstable angina: clinical, electrocardiographic, autonomic, and biochemical markers.

Authors:  S Kennon; C P Price; P G Mills; P K MacCallum; J Cooper; J Hooper; H Clarke; A D Timmis
Journal:  Heart       Date:  2003-01       Impact factor: 5.994

Review 10.  Where Does Inflammation Fit?

Authors:  Luigi M Biasucci; Giulio La Rosa; Daniela Pedicino; Alessia D'Aiello; Mattia Galli; Giovanna Liuzzo
Journal:  Curr Cardiol Rep       Date:  2017-09       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.